Cetuximab in Refractory Skin Cancer Treatment
<p><b>Objectives</b>: Non-melanoma skin cancer is the most common malignancy in US, with an annual incidence of in excess of 1.5 million cases. In the majority of cases, locoregional treatment is curative and systemic therapy is not indicated. Platinum-based chemotherapy regimens h...
| Published in: | Journal of Cancer |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Ivyspring International Publisher
2012-01-01
|
| Online Access: | http://www.jcancer.org/v03p0257.htm |